Literature DB >> 26580154

Breast cancer.

Chris Woolston.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26580154     DOI： 10.1038/527S101a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  54 in total

1.  MiR-124 reversed the doxorubicin resistance of breast cancer stem cells through STAT3/HIF-1 signaling pathways.

Authors:  Cong Liu; Hua Xing; Caixia Guo; Zhaoying Yang; Yimin Wang; Yingying Wang
Journal:  Cell Cycle       Date:  2019-07-29       Impact factor: 4.534

2.  Integrated Analysis of Genomic and Transcriptomic Profiles Identified the Role of GTP Binding Protein-4 (GTPBP4) in Breast Cancer.

Authors:  Yiming Hu; Jiaheng Xie; Liang Chen; Qikai Tang; Wei Wei; Wenfeng Lin; Wang Du; Tinghong Xiang; Lu Yin; Jing Ji
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

3.  KMT2C is a potential biomarker of prognosis and chemotherapy sensitivity in breast cancer.

Authors:  Xinhua Liu; Rongfang Qiu; Min Xu; Miaomiao Meng; Siyu Zhao; Jiansong Ji; Yang Yang
Journal:  Breast Cancer Res Treat       Date:  2021-07-08       Impact factor: 4.872

4.  Identification of markers associated with brain metastasis from breast cancer through bioinformatics analysis and verification in clinical samples.

Authors:  Yongchang Gao; Jianjing Liu; Xiaolong Qian; Xianghui He
Journal:  Gland Surg       Date:  2021-03

5.  Resibufogenin suppresses tumor growth and Warburg effect through regulating miR-143-3p/HK2 axis in breast cancer.

Authors:  Ying Guo; Fei Liang; Fuli Zhao; Jian Zhao
Journal:  Mol Cell Biochem       Date:  2020-01-31       Impact factor: 3.842

6.  Mixed invasive ductal and lobular carcinoma has distinct clinical features and predicts worse prognosis when stratified by estrogen receptor status.

Authors:  Yi Xiao; Ding Ma; Miao Ruan; Shen Zhao; Xi-Yu Liu; Yi-Zhou Jiang; Zhi-Ming Shao
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

7.  Breast Tumor-Derived Exosomal MicroRNA-200b-3p Promotes Specific Organ Metastasis Through Regulating CCL2 Expression in Lung Epithelial Cells.

Authors:  Pengfei Gu; Mayu Sun; Lei Li; Yang Yang; Zheshun Jiang; Yang Ge; Wenbo Wang; Wei Mu; Hui Wang
Journal:  Front Cell Dev Biol       Date:  2021-06-24

Review 8.  The Application of Citrus folium in Breast Cancer and the Mechanism of Its Main Component Nobiletin: A Systematic Review.

Authors:  Yuan Wu; Chien-Shan Cheng; Qiong Li; Jing-Xian Chen; Ling-Ling Lv; Jia-Yue Xu; Kai-Yuan Zhang; Lan Zheng
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-29       Impact factor: 2.629

9.  Ruyiping formula inhibits metastasis via the microRNA-134-SLUG axis in breast cancer.

Authors:  Ziwei Jiang; Lixia Pei; Ying Xie; Qun Ye; Xiaoqiang Liang; Yiyi Ye; Sheng Liu
Journal:  BMC Complement Med Ther       Date:  2021-07-05

10.  Effects of Ulinastatin on Proliferation and Apoptosis of Breast Cancer Cells by Inhibiting the ERK Signaling Pathway.

Authors:  Zeyu Xing; Xin Wang; Jiaqi Liu; Gang Liu; Menglu Zhang; Kexin Feng; Xiang Wang
Journal:  Biomed Res Int       Date:  2021-07-30       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.